ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
ResMed (RMD) Tops Q3 EPS by 3c, Revenues Miss
April 29, 2021 4:26 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $1.30, $0.03 better than the analyst estimate of $1.27. Revenue for the quarter came in at $768.8 million versus the consensus estimate of $793.17 million.
Third Quarter 2021 HighlightsAll comparisons are to the prior year period
Revenue was comparable at $768.8 million; down 3% on a constant currency basisGAAP gross margin of 58.2%; non-GAAP gross margin contracted 40 bps to 59.6%Net operating profit increased 3%; non-GAAP operating profit up 2%GAAP diluted earnings... More